Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066701 · ClinicalTrials.gov registry record
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 250
- Enrollment target
NCT02066701: Completed study, sponsored by Mayo Clinic.
NCT02066701 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02066701 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
This study is to identify potential markers from esophageal biopsies and brush cytology for feasibility of use in stool specimens for detection of Barretts Esophagus.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02066701
The ClinicalTrials.gov registry entry for NCT02066701 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02066701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02066701 about?
NCT02066701 is a clinical study titled "Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers". This study is to identify potential markers from esophageal biopsies and brush cytology for feasibility of use in stool specimens for detection of Barretts Esophagus.
What is the current status of trial NCT02066701?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2012-05. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02066701?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.